The missing link between clinical states and biomarkers in mental disorders

Psychotherapy and Psychosomatics

Volumn 83, Issue 3, 2014, Pages 136-141

  Fava, Giovanni A ^a,b,d   Guidi, Jenny ^a   Grandi, Silvana ^a   Hasler, Gregor ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d Department of Psychology ^*  (Italy)

Author keywords

Antidepressant agents; Biological psychiatry; Biomarkers; Clinical judgment; Clinimetrics; Depressive disorder; Mental disorders; Psychiatric diagnosis; Staging; Tolerance

Indexed keywords

BIOLOGICAL MARKER; ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT;

ARTICLE; DECISION MAKING; DEPRESSION; HEALTH STATUS; HUMAN; MEDICAL RESEARCH; MENTAL DISEASE; NEUROBIOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHIATRY; CLASSIFICATION; MENTAL DISORDERS; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); BIPOLAR DISORDER; BRAIN SIZE; DISEASE ASSOCIATION; DISEASE MARKER; DOCTOR PATIENT RELATION; GRAY MATTER; MAJOR DEPRESSION; PANIC; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; SCHIZOPHRENIA;

BIOLOGICAL MARKERS; BIOLOGICAL PSYCHIATRY; HUMANS; JUDGMENT; MENTAL DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84897967295     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000360348     Document Type: Article

References (62)

1. Kapur S, Phillips AG, Insel TR: Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry 2012; 17:1174-1179.
2. Insel T, Cuthbert B, Gavery M, Heinssen R, Pine DS, Quinn K, Sanislow C, Wang P: Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010; 167: 748-751.
3. Nissen SE: Biomarkers in cardiovascular medicine: the shame of publication bias. JAMA Intern Med 2013; 173:671-672.
4. Tzoulaki I, Siontis KC, Evangelou E, Ioanni-dis JPA: Bias in associations of emerging bio-markers with cardiovascular disease. JAMA Intern Med 2013; 173:664-671.
5. Woodcock J: Assessing the clinical utility of diagnostics used in drug therapy. Clin Pharmacol Ther 2010; 88:765-773.
6. Kellermann NP: Epigenetic transmission of holocaust trauma: can nightmares be inherited? Isr J Psychiatry Relat Sci 2013; 50:33-37.
7. McIntyre JS, Romano J: Is there a stethoscope in the house (and is it used)? Arch Gen Psychiatry 1977; 34:1147-1151.
8. Koranyi EK, Potoczny WM: Physical illnesses underlying psychiatric symptoms. Psychoth-er Psychosom 1992; 58:155-160.
9. Lipowski ZJ: Organic mental disorders: introduction and review of syndromes; in Kaplan HI, Freedman AM, Sadock BJ (eds): Comprehensive Textbook of Psychiatry/III. Baltimore, Williams & Wilkins, 1980, pp 1359-1392.
10. Fava GA, Sonino N: Depression associated with medical illness: treatment implications. CNS Drugs 1996; 5:175-189.
11. Winokur G: All roads lead to depression: clinically homogeneous, etiologicall heterogeneous. J Affect Disord 1997; 45:97-108.
12. Sonino N, Fallo F, Fava GA: Psychosomatic aspects of Cushing's syndrome. Rev Endocr Metab Disord 2010; 11:95-104.
13. Reus VI, Wolkowitz OM: Antiglucocorti-coid drugs in the treatment of depression. Expert Opin Investig Drugs 2001; 10: 1789-1796.
14. Gold PW, Chrousos P: Melancholic and atypical subtypes of depression represent distinct pathophysiological entities. Mol Psychiatry 2013; 18:632-634.
15. Fava GA: Clinical judgment: requiem or reveille? Nord J Psychiatry 2013; 67:1-10.
16. Lipowski ZJ: Psychopathology as a science: its scope and tasks. Comp Psychiatry 1966; 7: 175-182.
17. Feinstein AR: The Jones criteria and the challenges of clinimetrics. Circulation 1982; 66: 1-5.
18. Feinstein AR: Clinimetrics. New Haven, Yale University Press, 1987.
19. Fava GA, Tomba E, Sonino N: Clinimetrics: the science of clinical measurements. Int J Clin Practice 2012; 66:11-15.
20. Fava GA, Rafanelli C, Tomba E: The clinical process in psychiatry: a clinimetric approach. J Clin Psychiatry 2012; 73:177-184.
21. Kendler KS, Thornton LM, Gardner CO: Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the 'kindling' hypothesis. Am J Psychiatry 2000; 157:1243-1251.
22. Tomba E, Bech P: Clinimetrics and clinical psychometrics. Psychother Psychosom 2012; 81:333-343.
23. Cosci F, Fava GA: Staging of mental disorders: systematic review. Psychother Psycho-som 2013; 82:20-34.
24. McGorry P, Hickie IB, Yung AR, Pantelis C, Jackson HJ: Clinical staging of psychiatric disorders. Aust N Z J Psychiatry 2006; 40:612-622.
25. Fava GA, Kellner R: Staging: a neglected dimension in psychiatric classification. Acta Psychiatr Scand 1993; 87:225-230.
26. Fava GA, Grandi S, Zielezny M, Canestrari R, Morphy MA: Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 1994; 151: 1295-1299.
27. Fava GA, Rafanelli C, Grandi S, Conti S, Bel-luardo P: Prevention of recurrent depression with cognitive behavioral therapy. Arch Gen Psychiatry 1998; 55:816-820.
28. Fava GA, Grandi S, Zielezny M, Rafanelli C, Canestrari R: Four year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 1996; 153: 945-947.
29. Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S: Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry 2004; 161:1872-1876.
30. Guidi J, Fava GA, Fava M, Papakostas GI: Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analy-sis. Psychol Med 2011; 41:321-331.
31. Tyrer P, Seivewright N, Ferguson B, Tyrer J: The general neurotic syndrome. Acta Psychi-atr Scand 1992; 85:201-206.
32. Fava GA, Guidi J, Semprini F, Tomba E, Soni-no N: Clinical assessment of allostatic load and clinimetric criteria. Psychother Psycho-som 2010; 79:280-283.
33. McEwen BS: Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 2008; 583:174-185.
34. McEwen BS: Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007; 87:873-904.
35. Offidani E, Ruini C: Psychobiological correlates of allostatic overload in a healthy population. Brain Behav Immun 2012; 26:284-291.
36. Tomba E, Offidani E: A clinimetric evaluation of the allostatic overload in the general population. Psychother Psychosom 2012; 81:378-379.
37. Offidani E, Rafanelli C, Gostoli S, Marchetti G, Roncuzzi R: Allostatic overload in patients with atrial fibrillation. Int J Cardiol 2012; 165: 375-376.
38. Porcelli P, Laera D, Mastrangelo D, Di Masi A: Prevalence of allostatic overload syndrome in patients with chronic cardiovascular disease. Psychother Psychosom 2012; 81:375-377.
39. Lichtenberg P, Belmarker RH: Subtyping major depressive disorder. Psychother Psycho-som 2010; 79:131-135.
40. Bech P: The struggle for subtypes in primary and secondary depression and their mode-specific treatment or healing. Psychother Psy-chosom 2010; 79:331-338.
41. Guidi J, Fava GA, Picardi A, Porcelli P, Bel-lomo, Grandi S, Grassi L, Pasquini P, Quarte-san R, Rafanelli C, Rigatelli M, Sonino N: Sub-typing depression in the medically ill by cluster analysis. J Affect Disord 2011; 132: 383-388.
42. Hasler G, Drevets WC, Manji H, Charney DS: Discovering endophenotypes for major depression. Neuropsychopharmacology 2004; 29:1765-1782.
43. Hasler G, Northoff G: Discovering imaging endophenotypes for major depression. Mol Psychiatry 2011; 16:604-619.
44. Tomba E: Nowhere patients. Psychother Psy-chosom 2012; 81:69-72.
45. Fava GA, Offidani E: The mechanisms of tolerance in antidepressant action. Prog Neuro-psychopharmacol Biol Psychiatry 2011; 35: 1593-1602.
46. Byrne SE, Rotschild AJ: Loss of antidepres-sant efficacy during maintenance therapy. J Clin Psychiatry 1998; 59:279-288.
47. Fava GA, Tomba E, Tossani E: Innovative trends in the design of therapeutic trials in psychopharmacology and psychotherapy. Prog Neuropsychopharmacol Biol Psychiatry 2013; 40:306-311.
48. Fusar-Poli P, Radua J, Frascarelli M, Mechelli A, Borgwardt S, Di Fabio F, Biondi M, Ioan-nidis JP, David SP: Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders. Hum Brain Mapp 2013, DOI: 10.1002/hbm.22384.
49. Engel GL: Physician scientists and scientific physicians. Am J Med 1987; 82:107-111.
50. Fava GA: The intellectual crisis of psychiatric research. Psychother Psychosom 2006; 75: 202-208.
51. Feinstein AR: The intellectual crisis in clinical science. Perspect Biol Med 1987; 30:215-230.
52. Hasler G: Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry 2010; 9:155-161.
53. Balon R: Clinical factor 2011. Psychother Psy-chosom 2012; 81:199-205.
54. Balon R: Clinical factor 2012. Psychother Psy-chosom 2013; 82:204-212.
55. Carroll BJ: Biomarkers in DSM-5:lost in translation. Aust N Z J Psychiatry 2013; 47: 676-681.
56. Feinstein AR: The pre-therapeutic classification of comorbidity in chronic disease. J Chron Dis 1970; 23:455-468.
57. Kendler KS: Toward a philosophical structure for psychiatry. Am J Psychiatry 2005; 162: 433-440.
58. Van Praag HM: Over the mainstream: diagnostic requirements for biological psychiatry research. Psychiatry Res 1997; 72:201-212.
59. Belmaker RH: The future of depression psy-chopharmacology. CNS Spectr 2008; 13:682-687.
60. Engel GL: How much longer should medicine's science be bound by a seventeenth century world view? Psychother Psychosom 1992; 57:3-16.
61. Fava GA, Ruini C, Tomba E, Wise TN: The biopsychosocial factor. Psychother Psycho-som 2012; 81:1-4.
62. Feinstein AR: Clinical Judgment. Baltimore, Williams & Wilkins, 1967.